Cardiovascular Events throughout the Disease Course in Chronic Myeloid Leukaemia Patients Treated with Tyrosine Kinase Inhibitors-A Single-Centre Retrospective Study.

Varga, Andreea; Tilea, Ioan; Petra, Dorina Nastasia; Tilinca, Mariana-Cornelia; Gliga, Mirela Liana; Demian, Smaranda

Varga, Andreea; Tilea, Ioan; Petra, Dorina Nastasia; Tilinca, Mariana-Cornelia; Gliga, Mirela Liana; Demian, Smaranda.

Afiliación

Varga A; Department ME2, Faculty of Medicine in English, "G. E. Palade" University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.
Tilea I; Department of Cardiology II, Emergency Clinical County Hospital, 540042 Targu Mures, Romania.
Petra DN; Department of Cardiology II, Emergency Clinical County Hospital, 540042 Targu Mures, Romania.
Tilinca MC; Department M4, Clinical Sciences, Faculty of Medicine, "G. E. Palade" University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.
Gliga ML; Department M4, Clinical Sciences, Faculty of Medicine, "G. E. Palade" University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.
Demian S; Department of Internal Medicine II, Emergency Clinical County Hospital, 540042 Targu Mures, Romania.

J Clin Med ; 9(10)2020 Oct 12.

Article en En | MEDLINE | ID: mdl-33053860

Palabras clave

cardiovascular risk; chronic myeloid leukaemia; comorbidities; tyrosine kinase inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Año: 2020 Tipo del documento: Article País de afiliación: Rumanía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google